Compagnie Lombard Odier SCmA’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-736
Closed -$55K 647
2022
Q4
$55K Buy
+736
New +$52.4K ﹤0.01% 464
2019
Q4
Sell
-5,000
Closed -$249K 540
2019
Q3
$252K Buy
+5,000
New +$246K 0.01% 228
2015
Q4
Sell
-3,832
Closed -$150K 948
2015
Q3
$150K Sell
3,832
-4,281
-53% -$170K 0.01% 455
2015
Q2
$309K Sell
8,113
-3,905
-32% -$137K 0.01% 369
2015
Q1
$397K Sell
12,018
-7,571
-39% -$232K 0.01% 349
2014
Q4
$524K Sell
19,589
-6,117
-24% -$158K 0.02% 256
2014
Q3
$625K Buy
25,706
+5,565
+28% +$141K 0.03% 276
2014
Q2
$510K Buy
20,141
+19,063
+1,768% +$445K 0.02% 315
2014
Q1
$23K Sell
1,078
-3,020
-74% -$65.2K ﹤0.01% 783
2013
Q4
$91K Buy
+4,098
New +$90.4K ﹤0.01% 665

Other funds holding HOLX

Compagnie Lombard Odier SCmA's HOLX Position: Q1 2023 in Review

Compagnie Lombard Odier SCmA sold out of Hologic (HOLX) in Q1 2023, closing a stake of 736 shares — an estimated $55K sold.

Compagnie Lombard Odier SCmA first reported a position in HOLX in Q4 2013 and held it in 10 quarters. The position peaked at $625K in Q3 2014. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Compagnie Lombard Odier SCmA reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 736 Hologic shares in Q1 2023, an estimated $55K.
  • Compagnie Lombard Odier SCmA first reported a position in Hologic in Q4 2013 and held it in 10 quarters.
  • Compagnie Lombard Odier SCmA's Hologic position peaked at $625K in Q3 2014.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2023, filed 1 May 2023.